Back to top

earnings-estimates-revisions: Archive

Zacks Equity Research

Allakos Inc. (ALLK) Moves to Buy: Rationale Behind the Upgrade

Allakos Inc. (ALLK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ALLKNegative Net Change

Zacks Equity Research

What Makes Old Second Bancorp (OSBC) a New Strong Buy Stock

Old Second Bancorp (OSBC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

OSBCNo Net Change

Zacks Equity Research

All You Need to Know About Pacira (PCRX) Rating Upgrade to Buy

Pacira (PCRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

PCRXNegative Net Change

Zacks Equity Research

Viking Therapeutics, Inc. (VKTX) Moves to Buy: Rationale Behind the Upgrade

Viking Therapeutics, Inc. (VKTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

VKTXNegative Net Change

Zacks Equity Research

Saratoga Investment (SAR) Moves to Strong Buy: Rationale Behind the Upgrade

Saratoga Investment (SAR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

SARPositive Net Change

Zacks Equity Research

Brokers Suggest Investing in Boeing (BA): Read This Before Placing a Bet

Based on the average brokerage recommendation (ABR), Boeing (BA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

BAPositive Net Change

Zacks Equity Research

Wall Street Analysts Think Dick's (DKS) Is a Good Investment: Is It?

According to the average brokerage recommendation (ABR), one should invest in Dick's (DKS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

DKSNegative Net Change

Zacks Equity Research

Wall Street Analysts Think Paypal (PYPL) Is a Good Investment: Is It?

The average brokerage recommendation (ABR) for Paypal (PYPL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

PYPLNegative Net Change

Zacks Equity Research

Wall Street Analysts Think Medical Properties (MPW) Is a Good Investment: Is It?

According to the average brokerage recommendation (ABR), one should invest in Medical Properties (MPW). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

MPWNegative Net Change

Zacks Equity Research

Darden Restaurants (DRI) Expected to Beat Earnings Estimates: Should You Buy?

Darden Restaurants (DRI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DRINegative Net Change

Zacks Equity Research

Analysts Estimate Winnebago Industries (WGO) to Report a Decline in Earnings: What to Look Out for

Winnebago (WGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

WGOPositive Net Change

Zacks Equity Research

Wall Street Analysts Predict a 28% Upside in Guidewire Software (GWRE): Here's What You Should Know

The mean of analysts' price targets for Guidewire Software (GWRE) points to a 27.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

GWREPositive Net Change

Zacks Equity Research

Can Immunocore Holdings PLC Sponsored ADR (IMCR) Climb 27% to Reach the Level Wall Street Analysts Expect?

The consensus price target hints at a 27.1% upside potential for Immunocore Holdings PLC Sponsored ADR (IMCR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

IMCRNegative Net Change

Zacks Equity Research

Wall Street Analysts Predict a 59% Upside in Sprinkler (CXM): Here's What You Should Know

The mean of analysts' price targets for Sprinkler (CXM) points to a 59.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

CXMPositive Net Change

Zacks Equity Research

Wall Street Analysts Look Bullish on Coke (KO): Should You Buy?

According to the average brokerage recommendation (ABR), one should invest in Coke (KO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

KONegative Net Change

Zacks Equity Research

Swatch Group AG (SWGAY) Upgraded to Buy: What Does It Mean for the Stock?

Swatch Group AG (SWGAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

SWGAYPositive Net Change

Zacks Equity Research

nVent (NVT) Moves to Strong Buy: Rationale Behind the Upgrade

nVent (NVT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

NVTNegative Net Change

Zacks Equity Research

MaxCyte, Inc. (MXCT) Moves to Buy: Rationale Behind the Upgrade

MaxCyte, Inc. (MXCT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MXCTNegative Net Change

Zacks Equity Research

Holcim Ltd Unsponsored ADR (HCMLY) Moves to Buy: Rationale Behind the Upgrade

Holcim Ltd Unsponsored ADR (HCMLY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

HCMLYPositive Net Change

Zacks Equity Research

OFS Capital (OFS) Upgraded to Strong Buy: Here's What You Should Know

OFS Capital (OFS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

OFSPositive Net Change

Zacks Equity Research

Wall Street Analysts Predict a 25% Upside in Arista Networks (ANET): Here's What You Should Know

The consensus price target hints at a 25.3% upside potential for Arista Networks (ANET). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

ANETNegative Net Change

Zacks Equity Research

Wall Street Analysts Think Allogene Therapeutics (ALLO) Could Surge 159%: Read This Before Placing a Bet

The mean of analysts' price targets for Allogene Therapeutics (ALLO) points to a 158.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

ALLONegative Net Change

Zacks Equity Research

Wall Street Analysts Believe Nomad Foods (NOMD) Could Rally 32%: Here's is How to Trade

The mean of analysts' price targets for Nomad Foods (NOMD) points to a 31.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

NOMDNegative Net Change

Zacks Equity Research

Wall Street Analysts Believe Sea Limited Sponsored ADR (SE) Could Rally 82%: Here's is How to Trade

The mean of analysts' price targets for Sea Limited Sponsored ADR (SE) points to an 81.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

SENegative Net Change

Zacks Equity Research

Can nCino (NCNO) Climb 59% to Reach the Level Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 59.4% in nCino (NCNO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

NCNOPositive Net Change